Determining parental origin of embryo aneuploidy: Analysis of genetic error observed in 305 embryos derived from anonymous donor oocyte IVF cycles

Molecular Cytogenetics

Volumn 7, Issue 1, 2014, Pages

  Sills, E Scott ^a,b   Li, Xiang ^c   Frederick, Jane L ^a   Khoury, Charlotte D ^a   Potter, Daniel A ^a  

^a HRC Fertility Orange County   (United States)

^b UNIVERSITY OF WESTMINSTER   (United Kingdom)

^c Division of Analytics and Quantitative Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANEUPLOIDY; ANONYMOUS OOCYTE DONATION; ARTICLE; BIOPSY; BLASTOCYST; CHROMOSOME 15; CHROMOSOME 22; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; EMBRYO; FEMALE; GENETIC SCREENING; HUMAN; IN VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; KARYOTYPING; OOCYTE DONATION; PARENTAL ORIGIN OF EMBRYO ANEUPLOIDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 84989322156     PISSN: None     EISSN: 17558166     Source Type: Journal    
DOI: 10.1186/s13039-014-0068-5     Document Type: Article

References (29)

1. Delhanty JD, Griffin DK, Handyside AH, Harper J, Atkinson GH, Pieters MH, Winston RM: Detection of aneuploidy and chromosomal mosaicism in human embryos during preimplantation sex determination by fluorescent in situ hybridisation, (FISH). Hum Mol Genet 1993, 2(8):1183-1185.
2. Iwarsson E, Lundqvist M, Inzunza J, Ahrlund-Richter L, Sjöblom P, Lundkvist O, Simberg N, Nordenskjöld M, Blennow E: A high degree of aneuploidy in frozen-Thawed human preimplantation embryos. Hum Genet 1999, 104(5):376-382.
3. Hodes-Wertz B, Grifo J, Ghadir S, Kaplan B, Laskin CA, Glassner M, Munné S: Idiopathic recurrent miscarriage is caused mostly by aneuploid embryos. Fertil Steril 2012, 98(3):675-680.
4. Domitrz J, Jagiełło E, Chrostowski B, Szamatowicz J, Wołczynski S: Contemporary methods of treating age-related infertility. Ginekol Pol 2005, 76(9):747-754.
5. Munné S, Ary J, Zouves C, Escudero T, Barnes F, Cinioglu C, Ary B, Cohen J: Wide range of chromosome abnormalities in the embryos of young egg donors. Reprod Biomed Online 2006, 12(3):340-346.
6. Shulman A, Frenkel Y, Dor J, Levran D, Shiff E, Maschiach S: The best donor. Hum Reprod 1999, 14(10):2493-2496.
7. Dean NL, Edwards RG: Oocyte donation-implications for fertility treatment in the nineties. Curr Opin Obstet Gynecol 1994, 6(2):160-165.
8. Sauer MV, Paulson RJ, Lobo RA: Reversing the natural decline in human fertility. An extended clinical trial of oocyte donation to women of advanced reproductive age. JAMA 1992, 268(10):1275-1279.
9. Reh A, Amarosa A, Licciardi F, Krey L, Berkeley AS, Kump L: Evaluating the necessity for universal screening of prospective oocyte donors using enhanced genetic and psychological testing. Hum Reprod 2010, 25(9):2298-2304.
10. Katsoff B, Check JH, Mitchell-Williams J: Defective oocytes are not a common cause of unexplained infertility as determined by evaluation of sharing oocytes between infertile donors and recipients. Clin Exp Obstet Gynecol 2013, 40(2):193-195.
11. Spandorfer SD, Davis OK, Barmat LI, Chung PH, Rosenwaks Z: Relationship between maternal age and aneuploidy in in vitro fertilization pregnancy loss. Fertil Steril 2004, 81(5):1265-1269.
12. Lydic ML, Liu JH, Rebar RW, Thomas MA, Cedars MI: Success of donor oocyte in in vitro fertilization-embryo transfer in recipients with and without premature ovarian failure. Fertil Steril 1996, 65(1):98-102.
13. Kawwass JF, Monsour M, Crawford S, Kissin DM, Session DR, Kulkarni AD, Jamieson DJ, National ART, Surveillance System (NASS) Group: Trends and outcomes for donor oocyte cycles in the United States, 2000-2010. JAMA 2013, 310(22):2426-2434.
14. Myers ER: Outcomes of donor oocyte cycles in assisted reproduction. JAMA 2013, 310(22):2403-2404.
15. Min JK, Hughes E, Young D, Gysler M, Hemmings R, Cheung AP, Goodrow GJ, Senikas V, Wong BC, Sierra S, Carranza Mamane B, Case A, Dwyer C, Graham J, Havelock J, Lee F, Lui K, Vause T, Society of Obstetricians and Gynecologists of Canada: Elective single embryo transfer following in vitro fertilization. J Obstet Gynaecol Can 2010, 32(4):363-377.
16. Ankum WM, Reitsma JB, Offringa M, Hippocratic role of Data Monitoring Committees: IVF with Preimplantation genetic screening, a promising new treatment with unexpectedly negative health outcomes: The Hippocratic role of data monitoring committees. Hum Reprod 2008, 23(1):1-3.
17. Twisk M, Mastenbroek S, Hoek A, Heineman MJ, Heineman MJ, van der Veen F, Bossuyt PM, Repping S, Korevaar JC: No beneficial effect of preimplantation genetic screening in women of advanced maternal age with a high risk for embryonic aneuploidy. Hum Reprod 2008, 23(12):2813-2817.
18. Gleicher N, Kushnir VA, Barad DH: Preimplantation genetic screening (PGS) still in search of a clinical application: A systematic review. Reprod Biol Endocrinol 2014, 12:22.
19. Larsen EC, Christiansen OB, Kolte AM, Macklon N: New insights into mechanisms behind miscarriage. BMC Med 2013, 11:154.
20. Sills ES, Collins GS, Salem SA, Jones CA, Peck AC: Balancing selected medication costs with total number of daily injections: A preference analysis of GnRH-Agonist and antagonist protocols by IVF patients. Reprod Biol Endocrinol 2012, 10:67.
21. Bronet F, Martínez E, Gaytán M, Liñán A, Cernuda D, Ariza M, Nogales M, Pacheco A, San Celestino M, Garcia-Velasco JA: Sperm DNA fragmentation index does not correlate with the sperm or embryo aneuploidy rate in recurrent miscarriage or implantation failure patients. Hum Reprod 2012, 27(7):1922-1929.
22. Walsh AP, Omar AB, Collins GS, Murray GU, Walsh DJ, Salma U, Sills ES: Application of EU tissue and cell directive screening protocols to anonymous oocyte donors in western Ukraine: data from an Irish IVF programme. J Obstet Gynaecol 2010, 30(6):613-616.
23. Higgins AS, Flanagan JD, Von Wald T, Hansen KA: Preconception cystic fibrosis screening in infertile couples using an expanded carrier screening test. Obstet Gynecol 2014, 123(Suppl 1):97S.
24. Sills ES, Schattman GL, Veeck LL, Liu HC, Prasad M, Rosenwaks Z: Characteristics of consecutive in vitro fertilization cycles among patients treated with follicle-stimulating hormone (FSH) and human menopausal gonadotropin versus FSH alone. Fertil Steril 1998, 69(5):831-835.
25. Johnson DS, Gemelos G, Baner J, Ryan A, Cinnioglu C, Banjevic M, Ross R, Alper M, Barrett B, Frederick J, Potter D, Behr B, Rabinowitz M: Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol. Hum Reprod 2010, 25(4):1066-1075.
26. Rabinowitz M, Sweetkind-Singer J, Banjevic M, Johnson DS, Kijacic D, Petrov D: System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals. US Patent 2007, 9:2007018467A1.
27. Johnson DS, Rabinowitz M, Banjevic M, Singer J, Cinnioglu C, Baner J, Keller J, Sheena J, Behr B: Leveraging parental genotypes to increase confidence in genotype calls on single cells. Hum Reprod 2008, 23(Suppl 1):i67.
28. Johnson DS, Mortazavi A, Myers RM, Wold B: Genome-wide mapping of in vivo protein-DNA interactions. Science 2007, 316(5830):1497-1502.
29. Wu H, Neale MC: Adjusted confidence intervals for a bounded parameter. Behav Genet 2012, 42(6):886-898.